Cytokines and Receptors Reagents and Kits
Abcam Human Chemokine Antibody Array Membrane (38 targets)
Human Chemokine Antibody Array Membrane (38 targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bovine Cytokine Antibody Array (10 Targets) - Quantitative.
Bovine Cytokine Antibody Array (10 Targets) - Quantitative.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bovine Cytokine Antibody Array (10 Targets) - Quantitative.
Bovine Cytokine Antibody Array (10 Targets) - Quantitative.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Echinomycin, HIF-1alpha inhibitor
Potent, reversible cell-permeable HIF-1α inhibitor
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 32 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 32 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 22 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 22 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 62 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 62 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 32 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 32 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 62 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 62 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cytokine Array Mouse Cytokine Antibody Array (Membrane, 22 Targets)
Cytokine Array Mouse Cytokine Antibody Array (Membrane, 22 Targets)
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 225002, non-peptide C x CR2 antagonist, 10MG
MW 352.14 g/mol, Purity >95%. A selective non-peptide CXCR2 antagonist. Inhibits IL-8 binding to CXCR2 (IC₅₀ = 22 nM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 297006, CCR3 antagonist, 10MG
MW 342.35 g/mol, Purity >99%. Highly potent, selective CCR3 antagonist (IC₅₀ = 2.5 μM). Displays 250-fold selectivity for CCR3 vs. CXCR1, CXCR2, CCR1 and CCR7 receptors. Potent inhibitor of Ca²+ mobilization induced by eotaxin, eotaxin-2 and MCP-4 in human eosinophils (IC₅₀ values are 210, 90 and 80 nM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 328437, CCR3 antagonist, 10MG
MW 378.4 Da, Purity >99%. A highly potent and selective CC chemokine receptor-3 (CCR3) antagonist (IC₅₀ = 4 nM). Shows >2500-fold selectivity over CCR7, CXCR1, CXCR2, C4aR and LTD₄ receptors. Inhibits Ca²+ mobilization induced by eotaxin, eotaxin-2 and MCP-4 (IC₅₀ values are 38, 35, and 20 nM, respectively). Also inhibits eosinophil chemotaxis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam JTE 607 dihydrochloride, 5MG
MW 597.4 Da, Purity >98%. Inhibits inflammatory cytokine production in human peripheral blood mononuclear cells (PBMC's), e.g. IC₅₀'s = 11 nM (TNF-α), 5.9 nM (IL-1β), 8.8 nM (IL-6), 7.3 nM (IL-8), and 9.1 nM (IL-10). Induces apoptosis in leukemia cells in vitro and prolongs survival in a mouse leukemia model.
The product is subject to the following: Abcam Restricted Use Statement
Abcam JTE 607 dihydrochloride, 25MG
MW 597.4 Da, Purity >98%. Inhibits inflammatory cytokine production in human peripheral blood mononuclear cells (PBMC's), e.g. IC₅₀'s = 11 nM (TNF-α), 5.9 nM (IL-1β), 8.8 nM (IL-6), 7.3 nM (IL-8), and 9.1 nM (IL-10). Induces apoptosis in leukemia cells in vitro and prolongs survival in a mouse leukemia model.
The product is subject to the following: Abcam Restricted Use Statement
- 1
- 2